Skip to main content
Figure 5 | Journal of Inflammation

Figure 5

From: Inflammation contributes to NKX3.1 loss and augments DNA damage but does not alter the DNA damage response via increased SIRT1 expression

Figure 5

ROS-mediated changes are partially restored upon NKX3.1 expression or LNAC treatment. A. LNAC treatment and B. NKX3.1 overexpression remarkably suppresses cellular proliferation when LNCaP cells are treated with CM (including 62 and 125 pg/ml of TNFα). LNAC (10 mM) or NKX3.1 overexpression restores the CM-mediated suppression in cell proliferation. HM-NKX3.1 was transfected into the cells 24 h before CM treatment. HM: Hismax control vector, NKX: HM-NKX3.1 transfection. The Xcelligence real-time cell proliferation assay system was used to evaluate cell proliferation. The blue arrows indicate when the treatments were performed.

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us